Baylor College of Medicine a research site for clinical trial targeting COVID pneumonia

Scientist in laboratory stock art
Baylor College of Medicine will be one of 50 research sites for a clinical trial testing the immunomodulator drug, Tocilizumab, on COVID-19 pneumonia. (Courtesy Pexels)

Baylor College of Medicine will be one of 50 research sites for a clinical trial testing the immunomodulator drug, Tocilizumab, on COVID-19 pneumonia. (Courtesy Pexels)

Baylor College of Medicine will be one of 50 research sites worldwide undergoing a clinical trial for a new treatment of patients with severe COVID-19 pneumonia.

The goal is to enroll an estimated 330 participants in total across all the testing sites by May 2020. The Baylor site is pulling from Baylor College of Medicine as well as Harris Health System’s Ben Taub Hospital, according to a news release.

“The organ most commonly affected by COVID-19 is the lung, causing pneumonia for some patients and leading to difficulty breathing,” said Dr. Ivan O. Rosas, chief of the pulmonary, critical care and sleep medicine section in the Department of Medicine and the lead investigator at the Baylor site in the release.

The drug Tocilizumab (TCZ) will be tested alongside placebo in a randomized, controlled study, where both the investigator and participant are blinded to who is receiving treatment. Eligible participants, including hospitalized patients diagnosed with severe COVID-19 pneumonia confirmed with chest imaging, will be given an IV infusion with either a predetermined dose of TCZ or a placebo drug and may be given additional dosages if they show no sign of improvement.

The drug is being tested because TCZ could potentially target the body’s immune response to the virus, which is thought to be abnormally increased and described by others as a “cytokine storm,” the hyper-immune response triggered by the viral pneumonia, according to the release.


The working hypothesis from researchers is that because TCZ has been successfully used to treat hyperimmune responses in cancer patients undergoing treatment with immunotherapy, then the drug should have a similar effect to those with severe COVID-19 pneumonia.

Biotechnology company Genentech is sponsoring the trial.
By Hunter Marrow
Hunter Marrow came to Community Impact Newspaper in January 2020. Before that, Hunter covered local news in Ontario, OR for three years, covering municipal issues, crime, and education across Malheur County and across the border into Idaho.


MOST RECENT

COVID-19 vaccines
DATA: Texas has vaccinated about 9% of estimated Phase 1 recipients

Over 1.1 million individuals from the Phase 1 population, which is estimated to include 13.5 million individuals total, have received at least one dose.

Bob Popinski, policy director of Raise Your Hand Texas, shared the organization's top education priorities for the ongoing legislative session. (Courtesy Adobe Stock)
‘What does virtual learning and remote learning look like moving forward?': Raise Your Hand Texas policy director talks legislative priorities

Bob Popinski is the director of policy for Raise Your Hand Texas, an Austin-based organization committed to improving public education. He spoke with Community Impact Newspaper in late December about the 87th legislative session, which began Jan. 12.

Houston City Hall aerial view
Houston City Council ethics committee to review speech policies

The discussion comes after Facebook posts by Council Member Greg Travis led to calls for his resignation or censure.

Bayou City Art Festival Downtown is scheduled to return in person in October. (Courtesy Katya Horner/Bayou City Art Festival)
Bayou City Art Festival scheduled for in-person return in October

The Memorial Park version of the festival will be celebrated through alternative virtual and smaller in-person events.

Condit Elementary School
Houston ISD closes Condit Elementary in Bellaire over COVID-19 concerns

According to the HISD COVID-19 dashboard, there are nine active cases at Condit Elementary, including six student cases.

Mayor Sylvester Turner issued a warning to bars and nightclubs across Houston and said he plans to go after any establishment seen disregarding capacity guidelines. (Screenshot via Twitter)
Mayor Sylvester Turner calls out concerts, clubs operating over capacity

Turner also reported 1,964 new cases of COVID-19 along with 17 virus-related deaths.

The North Bellaire Special Development District located at the former Chevron campus at 4800 Fournace Place is in the review process by Bellaire’s Planning and Zoning Commission. (Hunter Marrow/Community Impact Newspaper)
Bellaire P&Z mulls changes to create north Bellaire zoning district

Almost a year in the works, Bellaire has a new zoning ordinance up for consideration.

At a Jan. 15 emergency court hearing, officials came up with a plan to try to reduce the inmate population at the Harris County Jail that centers on hosting more bail reduction hearings. (Courtesy Brian Jackson/Adobe Stock)
With open beds dwindling, officials look for ways to reduce Harris County jail population

The inmate population at the Harris County Jail is rising, and officials are looking for ways to quickly ease the pressure as concerns grow over the ability to quarantine and restrict the spread of the coronavirus.

Bocca Italian Kitchen serves seasonal, Italian-inspired dishes, such as polenta and various pastas. (Courtesy Marco Torres)
Italian eateries open in Generation Park; Houston bike lane fines enforced and more local news

Read the latest business and community news from the Houston area.

Minute Maid Park
Houston Health Department vaccine appointments fill up in 16 minutes

The department will administer 5,000 doses at Minute Maid Park on Jan. 16 and 17.

Officials expect demand for the vaccine will be huge once it opens to the general public. (Courtesy Adobe Stock)
Montgomery County plans vaccine distribution; FDA warns of false negatives and more top Houston-area news

Read the most popular stories from the past week from the Houston area.